Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination With Intravenous Iron Supplementation or Doubling Erythropoietin Dose for Patients With Chemotherapy-induced Anaemia Inadequately Responsive to Initial Erythropoietin Treatment Alone

NCT02731378 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT02731378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02731378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination With Intravenous Iron Supplementation or Doubling Erythropoietin Dose for Patients With Chemotherapy-induced Anaemia Inadequately Responsive to Initial Erythropoietin Treatment Alone
Lead sponsor
Shanghai East Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2016
Completion date
November 30, 2019
Enrollment
603 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced anaemia